Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-13

Clinical Trial Update: Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety and feasibility of combining propranolol (Hemangiol) with oral metronomic vinorelbine (Navelbine) in children and adolescents…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemangiol (propranolol)
  • Navelbine (vinorelbine)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Pediatric Cancer | Phase 1 | Status: UNKNOWN